Trial
NCT00756782
A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma
Phase IIWITHDRAWNSAFETYConfidence: HIGH
Sponsor
Taiho Oncology, Inc.
Collaborators
—
Condition
Advanced Hepatocellular Carcinoma
Intervention
TAC-101
Why stopped
Terminated due to safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-04